Savana — Series B · €23M

Savana, a Madrid healthtech applying clinical natural language processing (its EHRead technology) to turn free-text electronic health records into real-world evidence, raised €23M (reported internationally as $25M) led by Conexo Ventures, the venture arm of GED Capital. The company has processed over 2 billion records from around 200 hospitals in 16 countries and will push into drug discovery.